Search Within

Enrico Derenzini

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Executive Committee, Center for Hematologic Malignancies (6)
  4. Hematologic Malignancies, Division of (6)
  5. Lymphoma (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. Anas Younes (6)
  2. Elisa De Stanchina (4)
  3. John Philip (4)
  4. Mary Scallion (4)
  5. Patrizia Mondello (4)
  6. Ronald Hendrickson (4)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (3)
  4. 2014 (1)
Publications
  1. Blood (3)
  2. Cancer Research (1)
  3. Cell Reports (1)
  4. Oncotarget (1)
Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (1)
  3. Cell Press (1)
  4. Impact Journals (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BET inhibition-induced GSK3β feedback enhances lymphoma vulnerability to PI3K inhibitors
    Journal Article

    Derenzini, E.; Mondello, P.; Erazo, T.; Portelinha, A.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Valli, D.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Journal Article

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V.; Hendrickson, R. C.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save
  • MYC-dependent PI3K and MCL-1 feedbacks attenuate BET inhibitors activity in diffuse large B-cell lymphoma
    Meeting Abstract

    Derenzini, E.; Mondello, P.; Liu, Y.; Scallion, M.; Asgari, Z.; Philip, J.; Hilden, P.; Djaballah, H.; Ouerfelli, O.; de Stanchina, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Characterization of a c-Rel inhibitor that mediates anticancer properties in hematologic malignancies by blocking NF-κB-controlled oxidative stress responses
    Journal Article

    Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Doubrovina, E.; Derenzini, E.; Ouk, S.; Tsai, J. J.; Smith, O. M.; Levy, E. R.; Kreines, F. M.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Targeted therapy of B cell lymphoma with a direct inhibitor of the NF-kappa B subunit c-Rel
    Meeting Abstract

    Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Ouk, S.; Doubrovina, E.; Doubrovin, M.; Derenzini, E.; Scallion, M. I.; Tsai, J. J.; Smith, O. M.; more...
    Blood (2014)

    Fulltext@MSK | Save